Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.
Tobin, W O
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. [electronic resource] - Journal of neurology Jul 2014 - 1405-12 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1432-1459
10.1007/s00415-014-7362-3 doi
Adult
Aged
Aspirin--therapeutic use
Clopidogrel
Dipyridamole--therapeutic use
Enzyme-Linked Immunosorbent Assay
Female
Humans
Ischemic Attack, Transient--blood
Longitudinal Studies
Male
Middle Aged
Pilot Projects
Platelet Aggregation Inhibitors--therapeutic use
Protein Precursors--blood
Statistics, Nonparametric
Stroke--drug therapy
Ticlopidine--analogs & derivatives
Time Factors
von Willebrand Factor--metabolism
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. [electronic resource] - Journal of neurology Jul 2014 - 1405-12 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1432-1459
10.1007/s00415-014-7362-3 doi
Adult
Aged
Aspirin--therapeutic use
Clopidogrel
Dipyridamole--therapeutic use
Enzyme-Linked Immunosorbent Assay
Female
Humans
Ischemic Attack, Transient--blood
Longitudinal Studies
Male
Middle Aged
Pilot Projects
Platelet Aggregation Inhibitors--therapeutic use
Protein Precursors--blood
Statistics, Nonparametric
Stroke--drug therapy
Ticlopidine--analogs & derivatives
Time Factors
von Willebrand Factor--metabolism